Home
>
US Stocks
>
Trillium Therapeutics Inc
Trillium Therapeutics Inc
TRIL

Trillium Therapeutics Inc

$17.510.69%

1D

1W

1M

1Y

3Y

5Y

Key Stats

Open
17.66
Today Low/High
17.5 / 17.69
52 Week Low/High
$5.99 / $20.96
Market Cap
$654.8M

Company Details

Trillium is an immuno-oncology company developing innovative therapies for the treatment of cancer. The company’s two clinical programs, TTI-621 and TTI-622, target CD47, a “don’t eat me” signal that cancer cells frequently use to evade the immune system.
Organisation
Trillium Therapeutics Inc
Employees
33
Industry
Health Technology

Discover more

Frequently Asked Questions

What is Trillium Therapeutics Inc share price today

Can Indians buy Trillium Therapeutics Inc shares?

How can I buy Trillium Therapeutics Inc shares from India?

Can Fractional shares of Trillium Therapeutics Inc be purchased?

What are the documents required to start investing in Trillium Therapeutics Inc stocks?

We are a SEBI registered investement advisor